Remove Blood Pressure Remove Clinical Trials Remove Data Remove Topical
article thumbnail

CBD Science Update

Project CBD

Over 200 scientists from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpiblished data. None of the participants had been using any cannabinoid-based products prior to this study.

CBD 218
article thumbnail

CBD Science Update

Project CBD

Just over 500 participants from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpublished data. CBD for hypertension. The results were mixed. Related story Can CBD Help Your Condition?

CBD 177
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

15 Incredible Health Benefits of CBD Oil

The Herb Collective

Brown fat, on the other hand, decreases weight gain by burning white fat, creating heat, and regulating blood sugar. Applied topically, the product counters the overproduction of abnormal skin cells that cause irritation on the surface of the skin. Heart disease remains the leading cause of death for men and women in the United States.

Oil 56
article thumbnail

Curaleaf shares down 8% after FDA sends warning letter over CBD health claims

Cannabis Law Report

The two most important of these are the ability to lower blood pressure, and the ability to promote good cholesterol and lower bad cholesterol.”. FDA approves a new drug on the basis of scientific data and information demonstrating that the drug is safe and effective. 331(d) and 355(a).

CBD 51
article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval.